.may 17, 2018 . ., looking for billing codes to identify emergency room visits, observation stays, and inpatient hospitalizations . . . .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . promoted content http://lm360.us/Delpriore-daughter-of-Grange-from-Li-On?Kirschner=126